OpenAI acquires Orchestra Bio to build drug-development AI agents
OpenAI is acquiring the startup Orchestra Bio and plans to merge it into its life-sciences AI platform Rosalind. The combined effort aims to build AI agents that help pharma teams coordinate drug development, including t...